Search
for
Sort by
Research 61–90 of 1000+
- Optimizing Skin Quality via AI-Enhanced Physical Activity
- Cardiovascular Disease-Associated Skin Conditions
- Optimizing Skin Quality via AI-Enhanced Physical Activity
- Applications of Engineered Skin Tissue for Cosmetic Component and Toxicology Detection
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- Autophagy: Guardian of Skin Barrier
- Acne
- Oral Retinoids in Dermatology
- 4. Bullous/Mucous Membrane
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Extensive scarring alopecia and widespread rash
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- What causes hidradenitis suppurativa ?—15 years after
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Lupus cutáneo crónico
- Botulinum toxin type A for the management of hidradenitis suppurativa.
- Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals—Insights into Microbial Dysbiosis: Final Results
- Netherton Syndrome: A Case-Based Review of Diagnosis, Management, and Emerging Treatments.
- Exploration of Natural Adsorbents for Applications in Pollution-Reducing Cosmetic Formulations
- Illuminating microflora: shedding light on the potential of blue light to modulate the cutaneous microbiome
- Spironolactone in hidradenitis suppurativa: a single-center
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- The role of the microbiome in scalp hair follicle biology and disease
- Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- Oral Lichen Planus
- Outcome domains in lichen sclerosus
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Successful management of Netherton syndrome using IVIG and dupilumab: A case report
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies